Iron oxide nanoparticles-loaded hydrogels for effective topical photothermal treatment of skin cancer

被引:21
作者
Amatya, Reeju [1 ,2 ]
Kim, Doyeon [3 ,4 ]
Min, Kyoung Ah [3 ,4 ]
Shin, Meong Cheol [1 ,2 ]
机构
[1] Gyeongsang Natl Univ, Coll Pharm, 501 Jinju Daero, Jinju 52828, Gyeongnam, South Korea
[2] Gyeongsang Natl Univ, Pharmaceut Sci Res Inst, 501 Jinju Daero, Gimhae 52828, Gyeongnam, South Korea
[3] Inje Univ, Coll Pharm, 197 Injero, Gyeongnam 50834, South Korea
[4] Inje Univ, Inje Inst Pharmaceut Sci & Res, 197 Injero, Gyeongnam 50834, South Korea
基金
新加坡国家研究基金会;
关键词
Iron oxide nanoparticles; Hydrogel; Photothermal therapy; Cancer; Topical application; GENE; GEL;
D O I
10.1007/s40005-022-00593-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose A hydrogel containing dextran-coated iron oxide nanoparticles (DEX-IONP) was developed, and its applicability in topical photothermal therapy (PTT) of skin cancer was explored in vitro and in vivo. Methods DEX-IONP carbopol hydrogel was prepared by adopting the pH-triggered in situ gel-forming method. After preparation, physical characteristics and the photothermal activities of the DEX-IONP gel were evaluated in vitro in varying DEX-IONP concentrations. The photothermal activity was further examined in B16F10 s.c. tumor-bearing mice. Lastly, the efficacy of DEX-IONP gel-based topical PTT was evaluated in vivo. Results The prepared DEX-IONP gel retained high viscosity favorable to maintain at the applied site. In addition, the DEX-IONP gel could induce effective heating by laser irradiation. The cellular and in vivo studies evidenced the applicability of DEX-IONP in topical PTT. Finally, the preliminary efficacy study results in the B16F10 s.c. mice model demonstrated that tumor volumes could be significantly reduced by the topical PTT with DEX-IONP gel. Notably, by a single PTT treatment with 100 mu gFe/mL DEX-IONP gel and applying 0.5 W laser power for 10 min, the tumor growth could be significantly inhibited by 85%. Conclusion Overall, our results demonstrate that DEX-IONP gels may serve as an effective topical PTT agent.
引用
收藏
页码:775 / 785
页数:11
相关论文
共 43 条
[1]  
Aiyalu R, 2016, BRAZ J PHARM SCI, V52, P493, DOI [10.1590/S1984-82502016000300015, 10.1590/s1984-82502016000300015]
[2]   In Vitro and In Vivo Evaluation of PEGylated Starch-Coated Iron Oxide Nanoparticles for Enhanced Photothermal Cancer Therapy [J].
Amatya, Reeju ;
Hwang, Seungmi ;
Park, Taehoon ;
Min, Kyoung Ah ;
Shin, Meong Cheol .
PHARMACEUTICS, 2021, 13 (06)
[3]   BSA/Silver Nanoparticle-Loaded Hydrogel Film for Local Photothermal Treatment of Skin Cancer [J].
Amatya, Reeju ;
Hwang, Seungmi ;
Park, Taehoon ;
Chung, Yoon Ju ;
Ryu, Sehee ;
Lee, Jihyeong ;
Cheong, Heesun ;
Moon, Cheol ;
Min, Kyoung Ah ;
Shin, Meong Cheol .
PHARMACEUTICAL RESEARCH, 2021, 38 (05) :873-883
[4]   Rheological properties and drug release characteristics of pH-responsive hydrogels [J].
Aminabhavi, TM ;
Agnihotri, SA ;
Naidu, BVK .
JOURNAL OF APPLIED POLYMER SCIENCE, 2004, 94 (05) :2057-2064
[5]   Magnetic Iron Oxide Nanoparticles: Synthesis, Characterization and Functionalization for Biomedical Applications in the Central Nervous System [J].
Ansari, Shoeb Anwar Mohammed Khawja ;
Ficiara, Eleonora ;
Ruffinatti, Federico Alessandro ;
Stura, Ilaria ;
Argenziano, Monica ;
Abollino, Ornella ;
Cavalli, Roberta ;
Guiot, Caterina ;
D'Agata, Federico .
MATERIALS, 2019, 12 (03)
[6]   Iron Oxide Nanoparticles for Biomedical Applications: A Perspective on Synthesis, Drugs, Antimicrobial Activity, and Toxicity [J].
Arias, Lais Salomao ;
Pessan, Juliano Pelim ;
Miranda Vieira, Ana Paula ;
Toito de Lima, Taynara Maria ;
Botazzo Delbem, Alberto Carlos ;
Monteiro, Douglas Roberto .
ANTIBIOTICS-BASEL, 2018, 7 (02)
[7]  
Chai QY, 2017, GELS-BASEL, V3, DOI 10.3390/gels3010006
[8]   Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors [J].
Chertok, Beata ;
Moffat, Bradford A. ;
David, Allan E. ;
Yu, Faquan ;
Bergemann, Christian ;
Ross, Brian D. ;
Yang, Victor C. .
BIOMATERIALS, 2008, 29 (04) :487-496
[9]   Ferumoxytol for treatment of iron deficiency anemia in patients with chronic kidney disease [J].
Coyne, Daniel W. .
EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (15) :2563-2568
[10]   Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications [J].
Dadfar, Seyed Mohammadali ;
Roemhild, Karolin ;
Drude, Natascha I. ;
von Stillfried, Saskia ;
Knuechel, Ruth ;
Kiessling, Fabian ;
Lammers, Twan .
ADVANCED DRUG DELIVERY REVIEWS, 2019, 138 :302-325